Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma
Clinical trial NCT05190445 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05190445
- Sponsor
- Pieris Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2023-02-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.